Financials
- Market Capitalization 23.82 M
- Employee 11
- Founded 1996
- CEO N/A
- Website www.cellectar.com
- Headquarter Delaware, United States
- FIGI BBG000G9WFQ5
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4504 | TVRD Tvardi Therapeutics, Inc. - Common Stock | 1.81 USD | 0.00% | -2.16% | -26.42% | -49.72% | 24.14 M USD | ||
| 4510 | MRKR Marker Therapeutics, Inc. - Common Stock | 1.42 USD | -2.74% | +1.43% | +19.33% | +44.90% | 23.68 M USD | ||
| 4513 | KZIA Kazia Therapeutics Limited - American Depositary Shares | 14.06 USD | -16.80% | +3.69% | +11.76% | +140.34% | 22.76 M USD | ||
| 4514 | GNTA Genenta Science S.p.A. - American Depositary Shares | 1.05 USD | +6.06% | -17.32% | -33.54% | -72.15% | 24.60 M USD |
Frequently asked questions about Cellectar Biosciences INC NEW
What is the Cellectar Biosciences INC NEW stock price today?
The current price of Cellectar Biosciences INC NEW (CLRB) is 2.52. Over the past 24 hours, the stock has changed by -0.79%. Follow the CLRB chart for real-time price dynamics.
What is the stock ticker of Cellectar Biosciences INC NEW?
Cellectar Biosciences INC NEW trades under the ticker CLRB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Cellectar Biosciences INC NEW stock going up?
CLRB has changed by -1.95% over the last week, -0.79% over the last month, and -19.75% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Cellectar Biosciences INC NEW?
Cellectar Biosciences INC NEW currently has a market capitalization of 23.82 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Cellectar Biosciences INC NEW earnings last quarter?
Last quarter, Cellectar Biosciences INC NEW reported earnings of -0.57 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Cellectar Biosciences INC NEW net income for the last quarter?
Cellectar Biosciences INC NEW reported net income of -6.93 M for the last quarter. The previous quarter showed -5.65 M, which means net income changed by -22.58%.
How many employees does Cellectar Biosciences INC NEW have?
As of the latest available data, Cellectar Biosciences INC NEW has 11 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Cellectar Biosciences INC NEW stock?
You can buy Cellectar Biosciences INC NEW (CLRB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Cellectar Biosciences INC NEW stock?
Investing in Cellectar Biosciences INC NEW requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CLRB chart and related analysis on metatrader.com as part of your research.